Posted by Michael Wonder on 11 Aug 2020
Proposal for new calcineurin inhibitor listings on the Pharmaceutical Schedule
11 August 2020 - As part of PHARMAC’s Annual Tender process, PHARMAC is proposing to list two new medicines on the Pharmaceutical Schedule with Special Authority restrictions and Hospital Indication restrictions.
As the Tender process is still in progress, the brand names, pricing and timing for these products to be listed is still to be determined; however, PHARMAC is seeking your feedback on the proposed restrictions for these products:
- Pimecrolimus cream 1% for eczema (atopic dermatitis) on the eyelid
- Tacrolimus ointment 0.1% for eczema (atopic dermatitis) on the face
